Verition Fund Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,037
| Closed | -$1.37M | – | 2923 |
|
|
2025
Q1 | $1.37M | Buy |
34,037
+13,755
| +68% | +$553K | 0.01% | 1425 |
|
|
2024
Q4 | $954K | Sell |
20,282
-17,581
| -46% | -$827K | ﹤0.01% | 1558 |
|
|
2024
Q3 | $2M | Buy |
37,863
+27,098
| +252% | +$1.43M | 0.01% | 996 |
|
|
2024
Q2 | $583K | Sell |
10,765
-151,554
| -93% | -$8.21M | ﹤0.01% | 1393 |
|
|
2024
Q1 | $11.4M | Buy |
+162,319
| New | +$11.4M | 0.08% | 243 |
|
|
2022
Q3 | – | Sell |
-6,970
| Closed | -$274K | – | 2463 |
|
|
2022
Q2 | $274K | Buy |
+6,970
| New | +$274K | 0.01% | 1695 |
|
|
2015
Q1 | – | Sell |
-15,988
| Closed | -$128K | – | 384 |
|
|
2014
Q4 | $128K | Buy |
+15,988
| New | +$128K | 0.03% | 259 |
|